Literature DB >> 25548380

Relative frequency, characteristics, and antimicrobial susceptibility patterns of Vibrio spp., Aeromonas spp., Chromobacterium violaceum, and Shewanella spp. in the northern territory of Australia, 2000-2013.

Gary N McAuliffe1, Jann Hennessy2, Robert W Baird2.   

Abstract

Vibrio, Aeromonas, Chromobacterium violaceum, and Shewanella (VACS) are water-associated Gram-negative organisms that can cause a variety of infections. The frequency, patient characteristics, and antimicrobial susceptibilities for 468 isolates from 442 patients from the Northern Territory were reviewed. Aeromonas spp. (312 of 468; 67%) were most commonly isolated followed by Vibrio spp. (71 of 468; 15%), Shewanella spp. (61 of 468; 13%), and C. violaceum (24 of 468; 5%). A strong male predominance was found (male to female ratio of 2.3:1). Skin and soft tissue isolations (373 of 468; 80%) from lower limb infections (222 of 371; 60%) were the most common clinical manifestation. The episodes were usually polymicrobial (281 of 468; 60%). Coisolates included Staphylococcus aureus (137 of 468; 29%), β-hemolytic streptococci (74 of 468; 16%), enterobacteriaceae (111 of 468; 24%), non-fermentative Gram-negative bacilli (35 of 468; 7%), and other VACS organisms (37 of 468; 8%). Antimicrobial resistance of VACS organisms to ciprofloxacin (0-4%), cefepime (0-3%), and gentamicin (0-0.8%) and Vibrio spp., Aeromonas spp., and Shewanella to cotrimoxazole (0-3%) was rarely shown. For water-associated lower limb skin and soft tissue infections in the tropics, clinicians should consider empirical antimicrobial therapy with agents active against S. aureus and VACS organisms. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2014        PMID: 25548380      PMCID: PMC4350559          DOI: 10.4269/ajtmh.14-0715

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  29 in total

1.  In vitro antimicrobial susceptibility of clinical isolates of Aeromonas caviae, Aeromonas hydrophila and Aeromonas veronii biotype sobria.

Authors:  Jordi Vila; Francesc Marco; Lara Soler; Matilde Chacon; Maria José Figueras
Journal:  J Antimicrob Chemother       Date:  2002-04       Impact factor: 5.790

Review 2.  Complexity of β-lactamases among clinical Aeromonas isolates and its clinical implications.

Authors:  Po-Lin Chen; Wen-Chien Ko; Chi-Jung Wu
Journal:  J Microbiol Immunol Infect       Date:  2012-09-29       Impact factor: 4.399

3.  Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.

Authors:  W C Ko; H C Lee; Y C Chuang; C C Liu; J J Wu
Journal:  J Infect       Date:  2000-05       Impact factor: 6.072

4.  Essential role for estrogen in protection against Vibrio vulnificus-induced endotoxic shock.

Authors:  S M Merkel; S Alexander; E Zufall; J D Oliver; Y M Huet-Hudson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Comparison of the in vitro activity of ciprofloxacin and 24 other antimicrobial agents against clinical strains of Chromobacterium violaceum.

Authors:  K E Aldridge; G T Valainis; C V Sanders
Journal:  Diagn Microbiol Infect Dis       Date:  1988-05       Impact factor: 2.803

Review 6.  Human infection with Shewanella putrefaciens and S. algae: report of 16 cases in Martinique and review of the literature.

Authors:  Nicolas Vignier; Morgane Barreau; Claude Olive; Emilie Baubion; Rafaelle Théodose; Patrick Hochedez; André Cabié
Journal:  Am J Trop Med Hyg       Date:  2013-05-20       Impact factor: 2.345

7.  Decreasing prevalence of Trichuris trichiura (whipworm) in the Northern Territory from 2002 to 2012.

Authors:  Amy L Crowe; Pam Smith; Linda Ward; Bart J Currie; Rob Baird
Journal:  Med J Aust       Date:  2014-03-17       Impact factor: 7.738

8.  Increasing rates of vibriosis in the United States, 1996-2010: review of surveillance data from 2 systems.

Authors:  Anna Newton; Magdalena Kendall; Duc J Vugia; Olga L Henao; Barbara E Mahon
Journal:  Clin Infect Dis       Date:  2012-06       Impact factor: 9.079

Review 9.  Emerging Aeromonas species infections and their significance in public health.

Authors:  Isoken H Igbinosa; Ehimario U Igumbor; Farhad Aghdasi; Mvuyo Tom; Anthony I Okoh
Journal:  ScientificWorldJournal       Date:  2012-06-04

10.  In vivo efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus sepsis.

Authors:  Hee-Chang Jang; Su-Mi Choi; Hee Kyung Kim; Sung-Eun Kim; Seung-Ji Kang; Kyung-Hwa Park; Phil Youl Ryu; Tae-Hoon Lee; Young Ran Kim; Joon Haeng Rhee; Sook-In Jung; Hyon E Choy
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

View more
  7 in total

1.  The Spectrum of Chromobacterium violaceum Infections from a Single Geographic Location.

Authors:  Yi dan Lin; Suman S Majumdar; Jann Hennessy; Robert W Baird
Journal:  Am J Trop Med Hyg       Date:  2016-02-22       Impact factor: 2.345

2.  Waterborne Infections in Reunion Island, 2010-2017.

Authors:  Nicolas Allou; Aurélien Soubeyrand; Nicolas Traversier; Romain Persichini; Caroline Brulliard; Dorothée Valance; Olivier Martinet; Sandrine Picot; Olivier Belmonte; Jérôme Allyn
Journal:  Am J Trop Med Hyg       Date:  2018-07-19       Impact factor: 2.345

3.  Shewanella spp. infections in Gran Canaria, Spain: retrospective analysis of 31 cases and a literature review.

Authors:  Alberto J Martín-Rodríguez; Oriol Martín-Pujol; Fernando Artiles-Campelo; Margarita Bolaños-Rivero; Ute Römling
Journal:  JMM Case Rep       Date:  2017-12-07

4.  Multiple Liver Abscesses with a Skin Pustule due to Chromobacterium violaceum.

Authors:  Naoki Matsuura; Megumi Miyoshi; Nana Doi; Saori Yagi; Etsuko Aradono; Takuroh Imamura; Rintaro Koga
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

5.  Distinct Antimicrobial Resistance Profiling Of Clinically Important Aeromonas Spp. In Southwest China: A Seven-Year Surveillance Study.

Authors:  Shuangshuang Yang; Tong He; Jide Sun; Shan Sun
Journal:  Infect Drug Resist       Date:  2019-09-18       Impact factor: 4.003

6.  Clinical significance and outcome of Aeromonas spp. infections among 204 adult patients.

Authors:  J Nolla-Salas; J Codina-Calero; S Vallés-Angulo; A Sitges-Serra; A Zapatero-Ferrándiz; M C Climent; J Gómez; J R Masclans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-03       Impact factor: 3.267

7.  Skin and soft-tissue infections associated with Aeromonas species in French Guiana: an 11-year retrospective study.

Authors:  M Devos; V Sainte-Rose; H Kallel; C Mayence; H Ouedraogo; F Djossou; M Demar; P Couppié; R Blaizot
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-14       Impact factor: 6.166

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.